Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort

被引：0
|
作者：
Canavesi, Giada [1 ]
Mena, Maurizio [1 ]
Zaninetta, Elena [2 ,3 ]
Gazzola, Lidia [2 ,3 ]
Bini, Teresa [2 ,3 ]
Orofino, Giancarlo [4 ,5 ]
De Vito, Andrea [6 ,7 ]
Madeddu, Giordano [6 ,7 ]
Grillo, Chiara [8 ,9 ]
Bartalucci, Claudia [10 ,11 ]
Centorrino, Federica [10 ,11 ]
Squillace, Nicola [12 ,13 ]
Bonfanti, Paolo [12 ,13 ]
Tiecco, Giorgio [14 ,15 ]
Foca, Emanuele [14 ,15 ]
Menozzi, Marianna [16 ,17 ]
Guaraldi, Giovanni [16 ,17 ]
Bana, Nicolas Brian [18 ]
Cavazza, Giovanni [18 ]
Rossotti, Roberto [18 ]
Lo Caputo, Sergio [8 ,9 ]
Di Biagio, Antonio [10 ,11 ]
Rusconi, Stefano [1 ]
机构：
[1] Osped Nuovo Legnano, Infect Dis Unit, ASST Ovest Milanese, Legnano, Italy
[2] San Paolo Hosp, Infect Dis Unit, ASST Santi Paolo & Carlo, Milan, Italy
[3] Dipartimento Sci Salute, Milan, Italy
[4] Amedeo Savoia Hosp, Infect Dis Unit, Turin, Italy
[5] Univ Turin, Turin, Italy
[6] Azienda Osped Univ Sassari, Infect Dis Unit, Sassari, Italy
[7] Univ Sassari, Sassari, Italy
[8] Azienda Osped Univ Osped Riuniti Foggia, Infect Dis Unit, Foggia, Italy
[9] Univ Foggia, Foggia, Italy
[10] Osped Policlin San Martino, Infect Dis Unit, Genoa, Italy
[11] Univ Genoa, Genoa, Italy
[12] IRCCS San Gerardo Tintori, Infect Dis Unit, Monza, Italy
[13] Univ Milano Bicocca, Monza, Italy
[14] Spedali Civili Brescia, Infect Dis Unit, Brescia, Italy
[15] Univ Brescia, Brescia, Italy
[16] Azienda Osped Univ Modena, Infect Dis Unit, Modena, Italy
[17] Univ Modena & Reggio Emilia, Modena, Italy
[18] ASST Grande Osped Metropolitano Niguarda, Infect Dis Unit, Milan, Italy
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2024年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P074
引用
收藏
页码：86 / 88
页数：3
相关论文
共 50 条
  • [1] Cabotegravir-Rilpivirine: The First Complete Long-Acting Injectable Regimen for the Treatment of HIV-1 Infection
    Durham, Spencer H.
    Chahine, Elias B.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (11) : 1397 - 1409
  • [2] The optimum implementation of long-acting injectable cabotegravir-rilpivirine in sub-Saharan Africa
    Dawood, Halima
    LANCET GLOBAL HEALTH, 2021, 9 (05): : E563 - E564
  • [3] Impact of rilpivirine cross-resistance on long-acting cabotegravir-rilpivirine in low and middle-income countries
    Steegen, Kim
    Chandiwana, Nomathemba
    Sokhela, Simiso
    Venter, Willem D. F.
    Hans, Lucia
    AIDS, 2023, 37 (06) : 1009 - 1011
  • [4] Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir-rilpivirine in clinical practice
    Borghetti, Alberto
    Farinacci, Damiano
    Ciccullo, Arturo
    Dusina, Alex
    Moschese, Davide
    Iannone, Valentina
    D'Angelillo, Anna
    Lombardi, Francesca
    Delle Donne, Valentina
    Massaroni, Valentina
    Visconti, Elena
    Tamburrini, Enrica
    Di Giambenedetto, Simona
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (10) : 4970 - 4974
  • [5] Implementing long-acting injectable cabotegravir and rilpivirine in Africa
    Orkin, Chloe
    Ring, Kyle
    LANCET INFECTIOUS DISEASES, 2024, 24 (10): : 1060 - 1061
  • [6] The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis
    Phillips, Andrew N.
    Bansi-Matharu, Loveleen
    Cambiano, Valentina
    Ehrenkranz, Peter
    Serenata, Celicia
    Venter, Francois
    Pett, Sarah
    Flexner, Charles
    Jahn, Andreas
    Revill, Paul
    Garnett, Geoff P.
    LANCET GLOBAL HEALTH, 2021, 9 (05): : E620 - E627
  • [7] Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV
    van der Wekken-Pas, Lena
    Weiss, Fabian
    Simon-Zuber, Charlotte
    Sebisch, Rena
    Wiese, Carmen
    van Leeuwen, Elisabeth
    Burger, David
    Colbers, Angela
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (06) : 1468 - 1471
  • [8] Appropriateness of virological monitoring with long-acting injectable cabotegravir and rilpivirine
    Ripamonti, Diego
    Borghetti, Alberto
    Zazzi, Maurizio
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (10) : 2720 - 2724
  • [9] Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People With HIV Who Are Virally Unsuppressed
    Hickey, Matthew D.
    Grochowski, Janet
    Mayorga-Munoz, Francis
    Oskarsson, Jon
    Imbert, Elizabeth
    Spinelli, Matthew
    Szumowski, John D.
    Appa, Ayesha
    Koester, Kimberly
    Dauria, Emily F.
    Mcnulty, Moira
    Colasanti, Jonathan
    Havlir, Diane V.
    Gandhi, Monica
    Christopoulos, Katerina A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 96 (03) : 280 - 289
  • [10] Two cases of NNRTI resistance developed through planned interruption to long-acting injectable (LAI) cabotegravir/rilpivirine to facilitate conception
    Coleman, Harry
    Chilton, Daniella
    HIV MEDICINE, 2022, 23 : 28 - 29
12345